In a series of congressional hearings next week, lawmakers will hash out the regulatory framework for the so-called mobile medical app industry, which according to one estimate could reach $26 billion within the next five years.

There are thousands of health care apps for smartphones — think calorie counters and heart rate monitors, just for starters — and lawyers say the vast majority aren’t expected to fall under the purview of the Food and Drug Administration.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]